Navigation Links
Ocular Biopharmaceutical Company Charlesson Announces $1.6MM in New Funding and Upcoming Presentations at The Association for Research in Vision and Ophthalmology
Date:4/21/2008

Company aims to develop novel therapies to prevent blindness

OKLAHOMA CITY, April 21 /PRNewswire/ -- Charlesson LLC, an ocular biopharmaceutical company, today announced that it is the recipient of two Small Business Innovative Research (SBIR) awards from the National Institutes of Health (NIH). The two grants total approximately $1,600,000 and will support development of a nanoparticle-formulated therapy for eye disease as well as commercialization of a preclinical genetic animal model for Age- Related Macular Degeneration (AMD). Dr. Rafal Farjo, Director of Research and Development at Charlesson, is principal investigator on both grants.

Mike Moradi, Chief Executive Officer of Charlesson said, "We are proud to be NIH's partner in success. These competitive grant awards demonstrate the national enthusiasm for our development activities and the success of Charlesson's ongoing research program." Since its inception in 2003, Charlesson has received 11 grants from the NIH. "We are also pleased to receive our first SBIR grant that will aid in the development of Charlesson's preclinical services division to provide outsourced ophthalmic research and development. In addition, these funds will greatly assist the company in expanding our scientific team and finalizing preclinical studies for an Investigational New Drug (IND) application with the U.S. Food and Drug Administration (FDA)," said Mr. Moradi.

Charlesson was awarded $210,357 in a Phase I SBIR award from the NIH to validate and commercialize a genetic mouse model of AMD. "An unmet need currently exists for a reliable genetic model of AMD that can be used to assess the efficacy of AMD-therapeutics in development. There are only a few genetic mouse models which have been reported to present with features of AMD, but this phenotype only develops at very late ages. Therefore, a genetic, reproducible, economical, and quantifiable mammalian AMD model is of great significance to aid in the
'/>"/>

SOURCE Charlesson LLC
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related biology technology :

1. Sirion Therapeutics Acquires Worldwide License to Develop New Treatment for Ocular Diseases
2. STAAR Surgicals Collamer(R) IOL Designated as a New Technology Intraocular Lens by the Centers for Medicare and Medicaid Services
3. China Biopharmaceuticals Holdings Announces Second Quarter 2007 Financial Results
4. XTL Biopharmaceuticals Announces Financial Results for the Six Months Ended June 30, 2007
5. Nabi Biopharmaceuticals to Present at Upcoming Industry Conferences
6. XTL Biopharmaceuticals Announces Presentation of Novel Pre-Clinical Inhibitors of Hepatitis C at an Upcoming International Scientific Conference
7. XTL Biopharmaceuticals Initiates Phase IIb Clinical Trial of Bicifadine for the Treatment of Diabetic Neuropathic Pain
8. Nabi Biopharmaceuticals Announces Sale of Nabi Biologics to Biotest AG
9. Keryx Biopharmaceuticals to Present at Bank of America Investment Conference
10. Morria Biopharmaceuticals Plc Announces Appointment of Dr. Rosemary Mazanet as Interim Chief Executive Officer
11. Keryx Biopharmaceuticals, Inc. Announces Appointment of Michael P. Tarnok to Board of Directors
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/24/2014)... 2014  United Therapeutics Corporation (NASDAQ: ... MDT ) has submitted a pre-market ... Administration (FDA) for the use of Medtronic,s SynchroMed ... a newly developed catheter) for use with United ... to patients with pulmonary arterial hypertension.   ...
(Date:12/24/2014)... , Dec. 24, 2014  Vermillion, Inc. (Nasdaq: ... gynecologic disease, announced today that the Company closed ... Oracle Investment Management, Jack W. Schuler , ... proceeds were $10.5 million, before offering expenses.  The ... general corporate purposes. Under the terms ...
(Date:12/24/2014)... 2014 “Preparative & Process Chromatography ... Consumables (Columns, Solvents, Buffers, Valves, Guages, Seals), Accessories, ... - Forecasts to 2019” provides a detailed overview ... market trends, and strategies impacting the preparative and ... forecasts of the revenue and share analysis. ...
(Date:12/24/2014)... Earlier this year in a June 24 ... the Adult Stem Cell Technology Center, LLC ( ASCTC ... appreciated unique property of adult tissue stem cells. ... in the Past, Important for the Future,” embodied the ... gave the address at the 4th World Congress on ...
Breaking Biology Technology:United Therapeutics Announces Submission Of Pre-Market Approval Application For Implantable Drug Infusion System To Deliver Remodulin 2United Therapeutics Announces Submission Of Pre-Market Approval Application For Implantable Drug Infusion System To Deliver Remodulin 3United Therapeutics Announces Submission Of Pre-Market Approval Application For Implantable Drug Infusion System To Deliver Remodulin 4Vermillion Announces Closing of Equity Financing 2Vermillion Announces Closing of Equity Financing 3Preparative and Process Chromatography Market is expected to reach $9 billion by 2019 - New Report by Marketsandmarkets 2Preparative and Process Chromatography Market is expected to reach $9 billion by 2019 - New Report by Marketsandmarkets 3Preparative and Process Chromatography Market is expected to reach $9 billion by 2019 - New Report by Marketsandmarkets 4Adult Stem Cell Technology Center, LLC’s Director Sherley's Address on What’s Holding Back Regenerative Medicine Featured on Omics Group Website 2Adult Stem Cell Technology Center, LLC’s Director Sherley's Address on What’s Holding Back Regenerative Medicine Featured on Omics Group Website 3Adult Stem Cell Technology Center, LLC’s Director Sherley's Address on What’s Holding Back Regenerative Medicine Featured on Omics Group Website 4
... BEIJING, May 1 Sinovac Biotech Ltd. (NYSE Amex: ... in China, today announced that it has filed its Annual ... Commission for the year ended December 31, 2008 on May ... now available on the Company,s website under the investor relations ...
... of $79.7 Million, Increase of 29% over First Quarter 2008- ... per Diluted Share, Increases of 14% and 20% over First ... Therapeutics Corporation (Nasdaq: UTHR ) today announced its ... Total revenues for the first quarter of 2009 were ...
... Earnings Conference Call to be Held on May 15, ... / 8:00 pm (Beijing/Shanghai/Hong Kong)SHANGHAI, May 1 /PRNewswire-Asia/ -- ... a leading pharmaceutical, biotechnology and medical device R&D outsourcing ... today announced that it will release financial results for ...
Cached Biology Technology:Sinovac Biotech Ltd. Files Annual Report on Form 20-F 2United Therapeutics Reports First Quarter 2009 Financial Results 2United Therapeutics Reports First Quarter 2009 Financial Results 3United Therapeutics Reports First Quarter 2009 Financial Results 4United Therapeutics Reports First Quarter 2009 Financial Results 5United Therapeutics Reports First Quarter 2009 Financial Results 6United Therapeutics Reports First Quarter 2009 Financial Results 7WuXi PharmaTech Schedules First-Quarter 2009 Earnings Release 2
(Date:12/19/2014)... 18, 2014 Research and Markets ( ... "Micro Market Monitor: North America Perimeter Security Systems Market" ... http://photos.prnewswire.com/prnh/20130307/600769 The North American perimeter ... of 3.6% from 2014 to 2019. Although the U.S. ... Canada is expected to grow at ...
(Date:12/17/2014)... YORK , Dec. 15, 2014  HITLAB ... Good Clinical Practices (GCP) audit to confirm its ... (FDA) regulations. This accomplishment enables HITLAB to conduct ... utilizing the highest principles for patient safety and ... improve global healthcare access, quality, and delivery with ...
(Date:12/11/2014)... 09, 2014 Research and Markets ... ( http://www.researchandmarkets.com/research/twhjll/biometrics_market ) has announced the addition ... Region 2015-2019"  report to their offering. ... is advances in technology. With continuous advances in ... to the latest standard that meets the needs ...
Breaking Biology News(10 mins):Micro Market Monitor: North America Perimeter Security Systems Market (Intrusion Detection Sensor, Video Surveillance, Communication/Alarm and Notification, Access Control System) 2Micro Market Monitor: North America Perimeter Security Systems Market (Intrusion Detection Sensor, Video Surveillance, Communication/Alarm and Notification, Access Control System) 3HITLAB Completes GCP Audit for FDA Smart Device & App Compliance 2Biometrics Market in the APAC Region 2015-2019: Key Vendors are 3M Cogent, NEC, Safran and Suprema 2
... New research on two promising gene therapies suggests that combining ... by Duchenne muscular dystrophy, but also prevents future injury from ... The Research Institute at Nationwide Children,s Hospital, is the first ... step toward clinical trials in patients. The findings were published ...
... China - In a study published in Cell ... have completed the genome sequencing and analysis of the ... the first published crocodilian genome, providing a good explanation ... temperature-dependent sex determination (TSD). The Chinese alligator ...
... the end of the Human Genome Project, the international ... cytosine, and guanineis unique to homo sapien DNA. This ... coded in the human genome, but as time went ... are controlled. Now, Harvard Stem Cell Institute Principal ...
Cached Biology News:Combined therapy could repair and prevent damage in Duchenne muscular dystrophy 2Combined therapy could repair and prevent damage in Duchenne muscular dystrophy 3Whole-genome sequencing uncovers the mysteries of the endangered Chinese alligator 2HSCI researchers extend human epigenomic map 2
Imject Freund's Incomplete Adjuvant (FIA)...
... The LTQ XL extends the MSn ... with powerful new tools to generate extensive ... and metabolism applications. , Multiple dissociation ... for predicted and unpredicted metabolites , Fast ...
... hands-off homogenization through a vortex adapter and a ... DNA without hand grinding; eliminating the need to ... Robust tubes - Includes tough customized tubes to ... , Flexible format - Compatible with vortexes, ...
... mass spectrometer enables high-throughput solutions for todays ... ion trap mass spectrometer is designed for ... fast cycle time and increased sensitivity of ... attractive price. The combination of fast ...
Biology Products: